# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 157


In regulation 203 (amendment of regulation 260 (package leaflets))—
(a) in paragraph (2), in the inserted paragraph (1A), after the first reference to “advanced therapy medicinal product” insert “for sale or supply in Great Britain only”;
(b) in paragraph (3), in the inserted text, after “advanced therapy medicinal product,” insert “for sale or supply in Great Britain only”;
(c) in paragraph (4)—
(i) omit “, Article 126a authorisation”;
(ii) after “UK marketing authorisation” insert “, EU marketing authorisation,”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/157 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-157
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.